The Diagnosis and Evaluation of Dilated Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Pathology

Background:

• Dilated cardiomyopathy (DCM) represents a common myocardial response to diverse genetic and environmental factors.
• Identifying specific etiologies is key for targeted treatments and family screening.
• A substantial percentage of DCM cases are linked to genetic or inflammatory origins.

Purpose of the Study:

• To emphasize the importance of a comprehensive work-up in DCM diagnosis and management.
• To highlight the prognostic and therapeutic implications of cardiac remodeling beyond standard measurements.
• To underscore the potential of early DCM detection for reducing morbidity and mortality.

Main Methods:

• Rigorous clinical evaluation to exclude alternative causes of left ventricular (LV) dilation and dysfunction.
• Measurement of LV size and ejection fraction for diagnosis and risk stratification.
• Assessment of cardiac remodeling, including myocardial fibrosis and mitral valve function.

Main Results:

• Myocardial fibrosis assessment predicts sudden cardiac death risk and LV functional recovery potential.
• Fibrosis assessment may guide cardioverter-defibrillator implantation decisions.
• Detailed mitral valve assessment is increasingly important with new percutaneous interventions.

Conclusions:

• Comprehensive DCM evaluation is essential for accurate diagnosis, risk stratification, and tailored treatment.
• Assessing cardiac remodeling provides critical prognostic information and therapeutic guidance.
• Early detection of pre-clinical DCM enables timely cardioprotective therapy, potentially reducing adverse outcomes.